Publications: Nuclear Medicine

Name:  Mike Sathekge

e-mail:  [email protected]

Tel:  012 354 1794

 

Publications of the past 5 years:

Original publications in ISI accredited journals:

  1. Ankrah AO, Span LFR, Klein HC, de Jong PA, Dierckx RAJO, Kwee TC, Sathekge MM, Glaudemans AWJM. Role of FDG PET/CT in monitoring treatment response in patients  with invasive fungal infections. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):174-183. doi: 10.1007/s00259-018-4192-z. Epub 2018 Oct 21. PubMed PMID:30343434.
  2. Lawal IO, Ankrah AO, Mokoala KMG, Popoola GO, Kaoma CA, Maes A, Mokgoro NP, Van de Wiele C, Sathekge MM. Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection. Nuklearmedizin. 2018 Sep;57(5):190-197. doi: 10.3413/Nukmed-0965-18-03. Epub 2018 Sep 28. PubMed PMID: 30267401.
  3. Lawal I, Louw L, Warwick J, Nyakale N, Steyn R, Lengana T, Lengana T, Ellmann  A, Kotze T, Vangu M, Vorster M, Sathekge M. The College of Nuclear Physicians of South Africa Practice Guidelines on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours. S Afr J Surg. 2018 Sep;56(3):55-64. PubMed PMID:30264945
  4. Sathekge M, Bruchertseifer F, Knoesen O, Reyneke F, Lawal I, Lengana T, Davis  C, Mahapane J, Corbett C, Vorster M, Morgenstern A. (225)Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138. doi: 10.1007/s00259-018-4167-0. Epub 2018 Sep 19. PubMed PMID: 30232539.
  5. Lawal IO, Ankrah AO, Popoola GO, Nyakale NE, Boshomane TG, Reyneke F, Lengana  T, Vorster M, Sathekge MM. 18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma. Nucl Med Commun. 2018 Nov;39(11):1005-1012. doi: 10.1097/MNM.0000000000000905. PubMed PMID: 30198974.
  6. Lengana T, Lawal IO, Boshomane TG, Popoola GO, Mokoala KMG, Moshokoa E, Maes A, Mokgoro NP, Van de Wiele C, Vorster M, Sathekge MM. (68)Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli? Clin Genitourin Cancer. 2018 Oct;16(5):392-401. doi: 10.1016/j.clgc.2018.07.009. Epub 2018 Jul 21. PubMed PMID: 30120038.
  7. Snyman LC, Bryant EP, Wethmar EI, de Greve T, Reyneke F, Sathekge MM, Lindeque BG, Abu-Rustum NR. Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients with Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection. Int J Gynecol Cancer. 2018 Sep;28(7):1432-1437. doi: 10.1097/IGC.0000000000001310. PubMed PMID: 30036220.
  8. Bracke N, Janssens Y, Wynendaele E, Tack L, Maes A, van de Wiele C, Sathekge M, De Spiegeleer B. Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin case. Q J Nucl Med Mol Imaging. 2018 Apr 24. doi: 10.23736/S1824-4785.18.03025-X. [Epub ahead of print] PubMed PMID: 29697217.
  9. Vorster M, Modiselle MR, Corbett CS, Lawal IO, Buscombe JR, Sathekge MM. First Results and Experience with PRRT in South Africa. World J Nucl Med. 2018 Apr-Jun;17(2):86-93. doi: 10.4103/wjnm.WJNM_25_17. PubMed PMID: 29719482; PubMed Central PMCID: PMC5905263.
  10. Muranda AZ, Greeff L, Sathekge MM, Lengano T, Karusseit VOL. Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report. BMC Nephrol. 2018 Apr 23;19(1):94. doi: 10.1186/s12882-018-0891-8. PubMed PMID: 29688849; PubMed Central PMCID: PMC5914020.
  11. Lawal IO, Vorster M, Ankrah AO, Sathekge MM. The optimal TSH level necessary  for successful radioiodine ablation of differentiated thyroid carcinoma, as well  as the time to reach this level, is a work in progress. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1270-1271. doi: 10.1007/s00259-018-3999-y. Epub 2018 Mar  29. PubMed PMID: 29594409.
  12. Ankrah AO, Glaudemans AWJM, Maes A, Van de Wiele C, Dierckx RAJO, Vorster M,  Sathekge MM. Tuberculosis. Semin Nucl Med. 2018 Mar;48(2):108-130. doi: 10.1053/j.semnuclmed.2017.10.005. Epub 2017 Nov 16. Review. PubMed PMID:29452616.
  13. Lawal IO, Ankrah AO, Popoola GO, Lengana T, Sathekge MM. Arterial inflammation in young patients with human immunodeficiency virus infection: Across-sectional study using F-18 FDG PET/CT. J Nucl Cardiol. 2018 Feb 7. doi:10.1007/s12350-018-1207-x. [Epub ahead of print] PubMed PMID: 29417417.
  14. Lawal I, Ankrah A, Sathekge M. Reply: Molecular Imaging of Bacteria in Patients Is an Attractive Fata Morgana, Not a Realistic Option. J Nucl Med. 2018  Apr;59(4):717. doi: 10.2967/jnumed.118.208595. Epub 2018 Feb 1. PubMed PMID:29419482.
  15. Giesel FL, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M, Neels O, Reyneke F, Haberkon U, Kopka K, Sathekge M. Intraindividual Comparison of (18)F-PSMA-1007 and (18)F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study. J Nucl Med. 2018 Jul;59(7):1076-1080. doi: 10.2967/jnumed.117.204669. Epub 2017 Dec 21. PubMed PMID: 29269569.
  16. Lengana T, van de Wiele C, Lawal I, Maes A, Ebenhan T, Boshomane T, Zeevaart  JR, Ankrah A, Mokgoro N, Vorster M, Sathekge M. 68Ga-PSMA-HBED-CC PET/CT imaging  in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study. Nucl Med Commun. 2018 Feb;39(2):179-185. doi: 10.1097/MNM.0000000000000791. PubMed PMID: 29257006.
  17. Ankrah AO, Klein HC, Span LFR, de Vries EFJ, Dierckx RAJO, Sathekge MM, Glaudemans AWJM. The Role of PET in Monitoring Therapy in Fungal Infections. Curr Pharm Des. 2018;24(7):795-805. doi: 10.2174/1381612824666171213101648. PubMed PMID: 29237376.
  18. Lengana T, Lawal I, Boshomane T, Ololade K, Reyneke F, Kaoma C, Mokgoro N, Vorster M, Sathekge M. Salivary Gland Activity Obscures Mandibular Metastasis of  Prostate Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET. Clin Nucl Med. 2018 Feb;43(2):106-109. doi: 10.1097/RLU.0000000000001926. PubMed PMID: 29232247.
  19. Vorster M, Buscombe J, Saad Z, Sathekge M. Past and Future of Ga-citrate for  Infection and Inflammation Imaging. Curr Pharm Des. 2018;24(7):787-794. doi: 10.2174/1381612824666171129200611. PubMed PMID: 29189131.
  20. Sathekge M, Garcia-Perez O, Paez D, El-Haj N, Kain-Godoy T, Lawal I, Estrada-Lobato E. Molecular imaging in musculoskeletal infections with (99m)Tc-UBI 29-41 SPECT/CT. Ann Nucl Med. 2018 Jan;32(1):54-59. doi: 10.1007/s12149-017-1219-7. Epub 2017 Nov 21. PubMed PMID: 29164482.
  21. Lawal IO, Ankrah AO, Mokgoro NP, Vorster M, Maes A, Sathekge MM. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT. Prostate. 2017 Aug;77(11):1205-1212. doi: 10.1002/pros.23379. Epub 2017 Jun 26. PubMed PMID: 28649735.
  22. Sathekge M, Lengana T, Maes A, Vorster M, Zeevaart J, Lawal I, Ebenhan T, Van  de Wiele C. (68)Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans. Eur J  Nucl Med Mol Imaging. 2017 Nov 4. doi: 10.1007/s00259-017-3852-8. [Epub ahead of  print] PubMed PMID: 29101444.
  23. Ebenhan T, Sathekge M, Lenagana T, Koole M, Gheysens O, Govender T, Zeevaart JR. (68)Ga-NOTA-functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry and First-in-Human Positron Emission Tomography/Computed Tomography Imaging of Infections. J Nucl Med. 2017 Oct 19. pii: jnumed.117.200048. doi: 10.2967/jnumed.117.200048. [Epub ahead of print] PubMed PMID: 29051342.
  24. Orunmuyi A, Modiselle M, Lengana T, Ebenhan T, Vorster M, Sathekge M. (68)Gallium-Arginine-Glycine-Aspartic Acid and (18)F-Fluorodeoxyglucose Positron  Emission Tomography/Computed Tomography in Chondroblastic Osteosarcoma of the Skull. Nucl Med Mol Imaging. 2017 Sep;51(3):271-273. doi: 10.1007/s13139-016-0400-6. Epub 2016 Feb 12. PubMed PMID: 28878856; PubMed Central PMCID: PMC5567611.
  25. Reyneke F, Mokgoro N, Vorster M, Sathekge M. Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: A case report. Medicine (Baltimore). 2017 Nov;96(46):e8687. doi: 10.1097/MD.0000000000008687. PubMed PMID: 29145302.
  26. Lawal I, Ankrah A, Ololade K, Modiselle M, Sathekge M. Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: A case report. Medicine (Baltimore). 2017 Nov;96(46):e8471. doi: 10.1097/MD.0000000000008471. PubMed PMID: 29145251.
  27. Ebenhan T, Mokaleng BB, Venter JD, Kruger HG, Zeevaart JR, Sathekge M. Preclinical Assessment of a (68)Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent. Molecules. 2017 Aug 24;22(9). pii: E1403. doi: 10.3390/molecules22091403. PubMed PMID: 28837117.
  28. Pfannkuchen N, Meckel M, Bergmann R, Bachmann M, Bal C, Sathekge M, Mohnike W, Baum RP, Rösch F. Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases. Pharmaceuticals (Basel). 2017 May 18;10(2).  pii: E45. doi: 10.3390/ph10020045. Review. PubMed PMID: 28524118; PubMed Central PMCID: PMC5490402.
  29. Lawal IO, Ololade KO, Lengana T, Reyneke F, Ankrah AO, Ebenhan T, Vorster M,  Sathekge MM. Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in Africa. Hell J Nucl Med. 2017 May-Aug;20(2):128-133. doi: 10.1967/s002449910553. Epub 2017 Jul 12. PubMed PMID: 28697189.
  30. Dutta J, Baijnath S, Somboro AM, Nagiah S, Albericio F, de la Torre BG, Marjanovic-Painter B, Zeevaart JR, Sathekge M, Kruger HG, Chuturgoon A, Naicker T, Ebenhan T, Govender T. Synthesis, in vitro evaluation, and (68) Ga-radiolabeling of CDP1 toward PET/CT imaging of bacterial infection. Chem Biol  Drug Des. 2017 Oct;90(4):572-579. doi: 10.1111/cbdd.12980. Epub 2017 Apr 17.PubMed PMID: 28328161.
  31. Sathekge M, Knoesen O, Meckel M, Modiselle M, Vorster M, Marx S. (213)Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1099-1100. doi: 10.1007/s00259-017-3657-9. Epub 2017 Mar 2. PubMed PMID: 28255795; PubMed Central PMCID: PMC5397654.
  32. Bracke N, Yao H, Wynendaele E, Verbeke F, Xu X, Gevaert B, Maes A, Van de Wiele C, Sathekge M, De Saeger S, De Spiegeleer B. In Vitro Functional Quality Characterization of NOTA-Modified Somatropins. Anal Chem. 2017 Mar 7;89(5):2764-2772. doi: 10.1021/acs.analchem.6b03601. Epub 2017 Feb 16. PubMed PMID: 28192978.
  33. Lawal I, Lengana T, Ololade K, Boshomane T, Reyneke F, Modiselle M, Vorster M, Sathekge M. (18)F-FDG PET/CT in the detection of asymptomatic malignant melanoma recurrence. Nuklearmedizin. 2017 Jun 12;56(3):83-89. doi: 10.3413/Nukmed-0864-16-11. Epub 2017 Feb 3. PubMed PMID: 28154879.
  34. Lawal IO, Nyakale NE, Harry LM, Lengana T, Mokgoro NP, Vorster M, Sathekge MM. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma. Nucl Med Commun. 2017 Mar;38(3):222-227. doi: 10.1097/MNM.0000000000000640. PubMed PMID: 28002173.
  35. Afaq A, Alahmed S, Chen SH, Lengana T, Haroon A, Payne H, Ahmed H, Punwani S, Sathekge M, Bomanji J. (68)Ga-PSMA PET/CT impact on prostate cancer management. J Nucl Med. 2017 Jul 26. pii: jnumed.117.192625. doi: 10.2967/jnumed.117.192625. [Epub ahead of print] PubMed PMID: 28747520.
  36. Lawal IO, Nyakale NE, Harry LM, Modiselle MR, Ankrah AO, Msomi AP, Mokgoro NP, Boshomane TG, de Wiele CV, Sathekge MM. The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2025-2033. doi: 10.1007/s00259-017-3766-5. Epub 2017 Jun 28. PubMed PMID: 28660348.
  37. Bresser PL, Sathekge MM, Makanjee CR, Van Wyk D, Vorster M. A randomized-controlled study of a modified technique to reduce extracardiac activity in myocardial perfusion imaging. Nucl Med Commun. 2017 Jan;38(1):21-28.  PubMed PMID: 27749775.
  38. Ebenhan T, Schoeman I, Rossouw DD, Grobler A, Marjanovic-Painter B, Wagener J, Kruger HG, Sathekge MM, Zeevaart JR. Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different (68)Ge/(68)Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans. Mol Imaging Biol. 2017 Jun;19(3):469-482. doi: 10.1007/s11307-016-1014-1. PubMed PMID: 27743211.
  39. Sathekge M. Letter from Guest Editor. Semin Nucl Med. 2016 Sep;46(5):370-2
  40. Sathekge M, Lengana T, Modiselle M, Vorster M, Zeevaart J, Maes A, Ebenhan T, Van de Wiele C. (68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):689-694. doi: 10.1007/s00259-016-3563-6. Epub 2016 Nov 8. PubMed PMID: 27822700; PubMed Central PMCID: PMC5323468.
  41.  Ankrah AO, Glaudemans AW, Sathekge MM, Klein HC. Imaging latent tuberculosis infection with radiolabeled nitroimidazoles. Clin Transl Imaging. 2016;4:157-159.
  42. Ankrah AO, van der Werf TS, de Vries EF, Dierckx RA, Sathekge MM, Glaudemans AW. PET/CT imaging of Mycobacterium tuberculosis infection. Clin Transl Imaging. 2016;4:131-144.
  43. Van de Wiele C, Rimbu A, Belhocine T, DE Spiegeleer B, Sathekge M, Maes A. Reversible mycordial perfusion defects in patients not suffering from obstructive epicardial coronary artery disease as assessed by coronary angiography: a review of the literature. Q J Nucl Med Mol Imaging. 2016 Mar 23. [Epub ahead of print]
  44. Ankrah AO, Sathekge MM, Dierckx RA, Glaudemans AW. Imaging fungal infections in children. Clin Transl Imaging. 2016;4:57-72.
  45. Bresser PL, Sathekge MM, Makanjee CR, Van Wyk D, Vorster M. A randomized-controlled study of a modified technique to reduce extracardiac activity in myocardial perfusion imaging. Nucl Med Commun. 2016 Oct 4. [Epub ahead of print] PubMed PMID: 27749775.
  46. Ebenhan T, Schoeman I, Rossouw DD, Grobler A, Marjanovic-Painter B, Wagener J, Kruger HG, Sathekge MM, Zeevaart JR. Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different (68)Ge/(68)Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans. Mol Imaging Biol. 2016 Oct 14. [Epub ahead of print] PubMed PMID: 27743211.
  47. Vorster M, Maes A, Wiele Cv, Sathekge M. Gallium-68 PET: A Powerful Generator-based Alternative to Infection and Inflammation Imaging. Semin Nucl Med. 2016 Sep;46(5):436-47.
  48. Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. Br Med Bull. 2016 Sep 10. [Epub ahead of print] Review. PubMed PMID: 27613996.
  49. Meintjes M, Sathekge M, Makanjee CR, Dickson JC, Endozo R, Rheeder P, Bomanji  J. Comparison of rubidium-82 myocardial blood flow quantification with coronary calcium score for evaluation of coronary artery stenosis. Nucl Med Commun. 2016 Feb;37(2):197-206.
  50. Sepini L, Jansen D, Jarvis N, Zeevaart JR. Complexation studies of 177 Lu with ethylenediaminetetramethylene phosphonic acid (EDTMP) as a bone pain palliative therapeutic radiopharmaceutical. Polyhedron. 2016 Feb 26;106:101-5.
  51. Sonopo MS, Pillay A, Chibale K, Marjanovic--‐Painter B, Donini C, Zeevaart JR. Carbon--‐14 radiolabeling and tissue distribution evaluation of MMV390048. Journal of Labelled Compounds and Radiopharmaceuticals. 2016 Jan 1.
  52. Rambanapasi C, Zeevaart JR, Buntting H, Bester C, Kotze D, Hayeshi R, Grobler A. Bioaccumulation and Subchronic Toxicity of 14 nm Gold Nanoparticles in Rats. Molecules. 2016 Jun 10;21(6):763.
  53. Ackermann J, Jansen D, Jarvis N, Muller A, Zeevaart JR. 223 Ra calix [4] arenecrown ether antibody conjugates as potential radiopharmaceuticals for the treatment of cancer. Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie. 2016 Aug 22;35(1).
  54. Sonopo MS, Venter K, Winks S, Marjanovic--‐Painter B, Morgans GL, Zeevaart JR. Carbon--‐14 radiolabelling and tissue distribution evaluation of a potential anti-TB compound. Journal of Labelled Compounds and Radiopharm Tarkin J, Joshi FR, Evans NR, Groves A, Gopalan D, Manavaki R, Kirkpatrick PJ, Coughlin PA, Buscombe J, Fryer TD, Bennett M. 68ga-dotatate vascular Inflammation imaging predicts high-risk plaque morphology and Culprit coronary lesions. Journal of the American College of Cardiology. 2016 Apr 5;67(13_S):1577-1577.3
  55. Tarkin JM, Joshi FR, Evans NR, Groves AM, Gopalan D, Manavaki R, Kirkpatrick PJ, Coughlin PA, Hayes P, Buscombe JR, Fryer TD. Somatostatin receptor pet reveals high-risk plaque inflammation. Atherosclerosis. 2016 Jan 1;244:e3.
  56. Koulouri O, Kandasamy N, Hoole AC, Gillett D, Heard S, Powlson AS, O’Donovan DG, Annamalai AK, Simpson HL, Akker SA, Aylwin SJ. Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11Cmethionine PET co-registered with MRI. European Journal of Endocrinology. 2016 Nov 1;175(5):485-98.
  57. Tarkin JM, Joshi FR, Evans NR, Groves AM, Gopalan D, Manavaki R, Kirkpatrick PJ, Coughlin PA, Buscombe JR, Fryer TD, Bennett MR. Use of somatostatin receptor PET to differentiate between high-risk and low-risk atherosclerotic lesions: a prospective clinical study. The Lancet. 2016 Feb 25;387:S97.
  58. Farahi N, Simmonds R, Loutsios C, Cullum I, Gillett D, Carroll D, McGlashan K, Griffiths L, Madhavan S, Tregay NC, Begg M. Use Of Radiolabelled Autologous Neutrophils To Measure Neutrophil Clearance In The Lung In Patients With COPD And In Healthy Subjects Following Lipopolysaccharide. Imaging. 2016 May;5:6.
  59. Farahi N, Simmonds R, Loutsios C, Gillett D, Cullum I, Carroll D, McGlashan K, Griffiths L, Madhavan S, Tregay NC, Begg M. Use Of Radiolabelled Autologous Neutrophils To Establish The Early Bio-Distribution Of Neutrophils In COPD And Healthy Volunteers Following Lipopolysaccharide Challenge. Liver. 2016 May;2(4.798):1-747.
  60. Rogowski W, Wachuła E, Lewczuk A, Buscombe JR, Seklecka N, Sankowski A, Ćwikła JB. Long-term efficacy of (90)Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasms. Future Oncol. 2016 Aug;12(16):1877-85. doi: 10.2217/fon-2016-0031. PubMed PMID: 27156864.
  61. Buscombe J. Selective Internal Radiation Therapy in Metastatic Carcinoma of the Colon: A Story of Nonintegrated Care? World J Nucl Med. 2016 May-Aug;15(2):79-80. doi: 10.4103/1450-1147.178010. PubMed PMID: 27134555; PubMed Central PMCID: PMC4809158.aceuticals. 2016 Jun 15;59(7):264-9.
  62. Ebenhan T, Vorster M, Marjanovic-Painter B, Wagener J, Suthiram J, Modiselle M, Mokaleng B, Zeevaart JR, Sathekge M. Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients. Molecules. 2015 Aug 14;20(8):14860-78. doi: 10.3390/molecules200814860. PubMed PMID: 26287143.
  63. Hudyana H, Maes A, Vandenberghe T, Fidlers L, Sathekge M, Nicolai D, Van de Wiele C. Accuracy of bone SPECT/CT for identifying hardware loosening in patients who underwent lumbar fusion with pedicle screws. Eur J Nucl Med Mol Imaging. 2015 Aug 13. [Epub ahead of print] PubMed PMID: 26266888.
  64. Lawal I, Vorster M, Boshomane T, Ololade K, Ebenhan T, Sathekge M. Metastatic  Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT. Clin Nucl Med.  2015 Sep;40(9):755-6. doi: 10.1097/RLU.0000000000000870. PubMed PMID: 26053729.
  65. Sathekge M, Modiselle M, Vorster M, Mokgoro N, Nyakale N, Mokaleng B, Ebenhan  T. ⁶⁸Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1482-3. doi: 10.1007/s00259-015-3066-x. Epub 2015 May 1. PubMed PMID: 25931036.
  66. Vorster M, Modiselle M, Ebenhan T, Wagener C, Sello T, Zeevaart JR, Moshokwa E, Sathekge MM. Fluorine-18-fluoroethylcholine PET/CT in the detection of prostate cancer: a South African experience. Hell J Nucl Med. 2015 Jan-Apr;18(1):53-9. PubMed PMID: 25840573.
  67. Mokaleng BB, Ebenhan T, Ramesh S, Govender T, Kruger HG, Parboosing R, Hazari  PP, Mishra AK, Marjanovic-Painter B, Zeevaart JR, Sathekge MM. Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived  compound as a potential PET/CT infection imaging agent. Biomed Res Int. 2015;:284354. doi: 10.1155/2015/284354. Epub 2015 Jan 28. PubMed PMID: 25699267; PubMed Central PMCID: PMC4324493.
  68. Vorster M, Doruyter A, Brink A, Mkhize S, Holness J, Malan N, Nyakale N, Warwick JM, Sathekge M. Appropriate indications for positron emission tomography/computed tomography, 2015. S Afr Med J. 2015 Oct 16;106(1):105-22.
  69. Bennie G, Vorster M, Buscombe J, Sathekge M. The Added Value of a Single-photon Emission Computed Tomography-Computed Tomography in Sentinel Lymph  Node Mapping in Patients with Breast Cancer and Malignant Melanoma. World J Nucl  Med. 2015 Jan-Apr;14(1):41-6. doi: 10.4103/1450-1147.150543. PubMed PMID: 25709544; PubMed Central PMCID: PMC4337007.
  70. Sathekge M, Stoltz A, Gheysens O. Rheumatic fever: a forgotten but still existing cause of fever of unknown origin detected on FDG PET/CT. Clin Nucl Med.  2015 Mar;40(3):250-2. doi: 10.1097/RLU.0000000000000619. PubMed PMID: 25546214.
  71. Mandiwana V, Kalombo L, Venter K, Sathekge M, Grobler A,  Zeevaart JR. Samarium oxide as a radiotracer to evaluate the in vivo biodistribution of PLGA nanoparticles. J Nanopart Res (2015) 17:375
  72. Ebenhan T, Gheysens O, Kruger HG, Zeevaart JR, Sathekge MM. Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging. Biomed Res Int. 2014;2014:867381. Epub 2014 Aug 27. Review. PubMed PMID: 25243191; PubMed Central PMCID: PMC4163393.
  73. Kruse V, Van de Wiele C, Borms M, Maes A, Pottel H, Sathekge M, Cocquyt V. CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve. Nuklearmedizin. 2014 Aug 6;53(4):131-8. doi: 10.3413/Nukmed-0634-13-12. PubMed PMID: 25100557.
  74. Van De Wiele C, Sathekge M, Maes A. Targeting monocytes and macrophages by means of SPECT and PET. Q J Nucl Med Mol Imaging. 2014 Sep;58(3):269-75. PubMed PMID: 24844256.
  75. Sathekge M, McFarren A, Dadachova E. Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond. Nucl Med Commun. 2014 Aug;35(8):792-6. doi: 10.1097/MNM.0000000000000139. PubMed PMID: 24781008; PubMed Central PMCID: PMC4077982.
  76. Vorster M, Maes A, Jacobs A, Malefahlo S, Pottel H, Van de Wiele C, Sathekge MM. Evaluating the possible role of 68Ga-citrate PET/CT in the characterization of indeterminate lung lesions. Ann Nucl Med. 2014 Jul;28(6):523-30. doi: 10.1007/s12149-014-0842-9. Epub 2014 Mar 29. PubMed PMID: 24682926.
  77. Vorster M, Maes A, Van de Wiele C, Sathekge MM. 68Ga-citrate PET/CT in Tuberculosis: A pilot study. Q J Nucl Med Mol Imaging. 2014 Mar 20. [Epub ahead of print] PubMed PMID: 24651268.
  78. Sathekge M. Differentiation of HIV-associated lymphoma from HIV-reactive adenopathy using quantitative FDG-PET and symmetry. Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):593-5. doi: 10.1007/s00259-014-2701-2. PubMed PMID: 24469259.
  79. Ebenhan T, Zeevaart JR, Venter JD, Govender T, Kruger GH, Jarvis NV, Sathekge  MM. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014 Feb;55(2):308-14. doi: 10.2967/jnumed.113.128397. Epub 2014 Jan 16. PubMed PMID: 24434293.
  80. Zinn, C., Vorster, M., & Sathekge, M. M. Spinal Tuberculosis Evaluated by Means of 18F-FDG PET/CT: Pilot Study. The Open Nuclear Medicine Journal, 2014, 6, 6-11
  81. Mokaleng BB, Ebenhan T, Ramesh S, Govender T, Kruger HG, R Parboosing, Hazari PP,  Mishra AK, Marjanovic-Painter B, Zeevaart JR, Sathekge MM. Synthesis, 68Ga-Radiolabeling, and Preliminary In Vivo Assessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent. Biomed Res Int. 2014;2014: Epub 2014. Research Article. PubMed PMID
  82. Ebenhan T, Chadwick N, Sathekge MM, Govender P, Govender T, Kruger HG, Marjanovic-Painter B, Zeevaart JR. Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT. Nucl Med Biol. 2014 May-Jun;41(5):390-400. doi: 10.1016/j.nucmedbio.2014.02.001. Epub 2014 Feb 13. PubMed PMID: 24630816.

 

Review articles in ISI accredited journals:

  1. Kleynhans J, Grobler AF, Ebenhan T, Sathekge MM, Zeevaart JR. Radiopharmaceutical enhancement by drug delivery systems: A review. J Control Release. 2018 Oct 10;287:177-193. doi: 10.1016/j.jconrel.2018.08.008. Epub 2018 Aug 4. Review. PubMed PMID: 30086338
  2. Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth. Curr Radiopharm. 2018;11(3):200-208. doi: 10.2174/1874471011666180502104524. PubMed PMID: 29732998.
  3. Sathekge MM, Ankrah AO, Lawal I, Vorster M. Monitoring Response to Therapy. Semin Nucl Med. 2018 Mar;48(2):166-181. doi: 10.1053/j.semnuclmed.2017.10.004. Epub 2017 Nov 13. Review. PubMed PMID: 29452619.
  4. Vorster M, Buscombe J, Saad Z, Sathekge M. Past and future of Ga-citrate for infection and inflammation imaging. Curr Pharm Des. 2017 Nov 29. doi: 10.2174/1381612824666171129200611. [Epub ahead of print] PubMed PMID: 29189131.
  1. Sathekge MM. Work-based assessment: A critical element of specialist medical training. S Afr Med J. 2017 Aug 25;107(9):12059. doi: 10.7196/SAMJ.2017.v107i9.12655. PubMed PMID: 28875875.
  1. Lawal I, Zeevaart J, Ebenhan T, Ankrah A, Vorster M, Kruger HG, Govender T, Sathekge M. Metabolic Imaging of Infection. J Nucl Med. 2017 Nov;58(11):1727-1732. doi: 10.2967/jnumed.117.191635. Epub 2017 Aug 17. Review. PubMed PMID: 28818989.
  1. Ankrah AO, Glaudemans AWJM, Klein HC, Dierckx RAJO, Sathekge M. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases. Nucl Med Mol Imaging. 2017 Jun;51(2):127-139.  doi: 10.1007/s13139-016-0422-0. Epub 2016 May 25. Review. PubMed PMID: 28559937;  PubMed Central PMCID: PMC5429294.
  1. Kgatle MM, Kalla AA, Islam MM, Sathekge M, Moorad R. Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy. Prostate Cancer. 2016;2016:5653862. Epub 2016 Nov 6. Review. PubMed PMID: 27891254; PubMed Central PMCID: PMC5116340.
  2. Sathekge M, Maes A, Van de Wiele C, Dadachova E. Invited Paper. Impact of AIDS in Women who have gender determined health issues. Sem Nucl Med. 2014 Nov.
  1.  Nyakale, N., Z. Lockhat, and M. M. Sathekge. Nuclear medicine-induced allergic reactions: review article. Current Allergy & Clinical Immunology 28, no. 1 (2015): 10-17.
  1. Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT. Curr Opin Pulm Med. 2014 May;20(3):287-93. doi: 10.1097/MCP.0000000000000043. PubMed PMID: 24614238.

 

Book chapters:

  1. Thomas Ebenhan and Mike Sathekge. Imaging in Developng World.  Imaging Infections Editor(s): Sanjay Jain, Published Online: 31 May 2017 (ISBN: 978-3-319-54590-5)
  2. Buscombe J. Therapeutic Nuclear Medicine in the UK. In: A History of Radionuclide Studies in the UK 2016 (pp. 121-128). Springer International Publishing.
  1. Chapter on Imaging of Antidepressant Drug Response Using SPECT and PET in; Ed. A van Waarde, R A J O Dierckx, AWJM Glaudemans. SPECT and PET in Neurology and Psychiatry. Springer Berlin Heidelberg, 2014. 325-345.
  1. Vorster, M., Nyakale, N., & Sathekge, M. (2014). Impulsivity Imaging. In PET and SPECT in Psychiatry (pp. 583-620). Springer Berlin Heidelberg.
  2. Titled "Diagnostic imaging of infections and inflammatory diseases: a multidisciplinary approach" In Press; Chapter 7 (Nuclear Medicine imaging of TB and HIV) in; A John Wiley Book, Edited by A Signore.
  1. Titled “Nuclear Medicine and Radiological Imaging in Sports Injuries”. In Press: “Nuclear medicine imaging of wrist, hand, and finger injuries”. A Springer-Verlag Book   Edited by A.W.J.M. Glaudemans , R.A.J.O. Dierckx , J. Gielen , J. Zwerver.
  1. Sathekge, Mike, Farhana Ebrahim Suleman, Mark D. Velleman, and Ralf Clauss. Nuclear Medicine Imaging  of Sport Injuries of the Wrist, Hand and Fingers. In Nuclear Medicine and Radiologic Imaging in Sports Injuries,  pp. 525-548. Springer Berlin Heidelberg, 2015.

 

Publications in non-ISI accredited journals:

 

Conference proceedings:

  1. M Modiselle, N Nyakale, MM Sathekge. Comparison of early versus delayed imaging in myocardial viability study using F18-FDG PET-CT. South African Society of Nuclear Medicine Congress, Pretoria, South Africa. 23-25 September 2016.
  2. M M Sathekge. Guest Speaker. Tuberculosis. SNMMI, San Diego,USA,  June 2016.
  1. M M Sathekge. Guest Speaker. Monitoring Response to therapy. SNMMI, San Diego, USA, June 2016.
  1. M M Sathekge. Guest Speaker. HIV and Tuberculosis. Boston University, USA, June 2016.
  1. Sathekge M M. Targeted Radionuclide Therapy in HIV. Invited Speaker. Advancing HIV Cure Research. Cape Town. 6-7 October 2016.
  1. M M Sathekge. Guest Speaker. PRRT in GEPNETS. HBPSA, Cape Town, 21 October 2016.
  1. Sathekge M M. PRRT in treatment of NET. Invited Speaker. NET Tour Worshop. Norvartis, Johannesburg. 29 October 2016.
  1. Sathekge M M. PSMA in Breast Cancer. Invited Speaker. Theranostic World Congress, Melbourne. Australia. November 2016.
  1. Sathekge M M. PSMA in Breast Cancer. Invited Speaker. Theranostic World Congress, Melbourne. Australia. November 2016.
  1. M M Sathekge. Guest Speaker. Nuclear Medicine in TB therapy. IRCT 2016, WARMTH, 15 November 2016. Kochi, India.
  1. M M Sathekge. Guest Speaker. Implementation of therapies in Africa. IRCT 2016, WARMTH, 16 November 2016. Kochi, India.
  1. Vorster M, Sathekge M M. Ga68 Citrtae in Tuberculosis. 17th ISORBE  Congress, 3-6 March 2015. Izmir, Turkey
  1. Nyakale NE, Ghambhir SS, Ankrah A, Sathekge M M . Clinical usefulness of  18F-Sodium Fluoride and 18F-FDG PET/CT Cocktail in management of Oncology patients. 10th ICRT (WARMTH) Congress, 3-8 May 2015. Innsbruck, Austria.
  1. M Modiselle, N Nyakale, MM Sathekge. The role of delayed imaging in myocardial in F18-FDG PET-CT myocardial viability study.10th ICRT (WARMTH) Congress, 3-8 May 2015. Innsbruck, Austria
  1. IO Lawal, T Boshomane, M Vorster, M Sathekge. Diagnostic value of 68Ga-DOTATATE PET/CT in neuroendocrine tumours. Faculty Day, UP. 18 August 2015.
  1. T Lengana, F Reyneke, N Nyakale, M Sathekge. 68GA-PSMA PET/CT in prostate cancer patients. Faculty Day, UP. 18 August 2015
  1. M Modiselle, M Vorster, M Sathekge. Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0);TYR(3)] OCTREOTATE in neuroendocrine tumours. Faculty Day, UP. 18 August 2015.
  1. K Ololade, N Mokgoro, M Sathekge. Metastatic pattern of 18F-FDG PET/CT in HIV positive patients with recurrent cervical cancer.Faculty Day, UP. 19 August 2015
  1. Sathekge M M. FDG in HIV and Tuberculosis. Plenary Speaker. 17th ISORBE Congress, 3-6 March 2015. Izmir, Turkey
  1. Sathekge M M. Infection imaging prosthesis. Faculty-Invited Speaker. 17th ISORBE Congress, 3-6 March 2015. Izmir, Turkey
  1. Sathekge M M. Advancing Nuclear Medicine through Innovation. Launch of Micro-PET/CT. Plenary Lecture. 23 April. NECSA
  1. Sathekge M M. 68Ga-PSMA PET/CT: Paradigm Shift in the Management of Prostate Cancer. Faculty-Invited Speaker. 10th ICRT (WARMTH) Congress, 3-8 May 2015. Innsbruck, Austria
  1. Sathekge M M. PET/CT in HIV and TB. Marie Grobbelaar Memorial lecture. Academic Day, University of Stellenbosch, 5 August 2015.
  1. Sathekge MM. Imaging – expanding the research focus through innovation. Faculty Day, UP. 19 August 2015 Guest Speaker
  1. Sathekge M M. Molecular imaging in cardiac infections. Plenary Speaker. NCSI-2015, Lucknow, India 2015.
  1. Sathekge M M. HIV and Vasculitis. Guest Speaker. NCSI-2015, Lucknow, India 2015.
  1. Sathekge M  M.  Peptides, small molecules and antibiotics for hybrid PET/CT and SPECT/CT imaging of infection. CME - Inflammation and Infection: Imaging Infection in the Immunocompromised Patient. EANM, Hamburg, Germany. 12 October 2015.
  1. Sathekge M M. SPECT and PET in Infection and Inflammation. Guest Speaker. IAEA. IPET 2015 Vienna, Austria, October 2015.
  1. Sathekge M M. PET in TB and AIDS. Plenary Speaker. IAEA. IPET 2015 Vienna, Austria, October 2015.
  1. Sathekge M M. Target Radionuclide Therapy in Prostate Cancer. Invited Speaker. SAPCS, UP, October 2015.
  1. Sathekge M M. Isotopes in Prostate Cancer. Guest Speaker. ESAU. CSIR, October 2015.
  1. M M Sathekge. Highlights Lecture, World Federation of Nuclear Medicine and Biology Congress, Cancun, Mexico. 27-31 August 2014.
  1. Mokaleng B, Ebenhan T, Govender T, Kruger G, Pulker T, Zeevaart J and Sathekge M. Synthesis of 68Ga-NOTA-TBI101 PET/CT imaging of infection., SASNM, Durban 2014.
  1. Modiselle M, Nyakale N, Sathekge M. Evaluating the role of dual phase FDG-PET/CT in viability. SASNM, Durban 2014.
  1. Orunmunyi  A, Vorster M,   Nyakale N, Sathekge M. Evaluating the role of FDG-PET/CT in oesophageal cancer. SASNM, Durban 2014.
  1. Modiselle M, Nyakale N, Sathekge M. Evaluating the role of dual phase FDG-PET/CT in viability. UP Academic Day 2014.
  1. Nyakale N and Sathekge M. FDG PET/CT imaging of infection. SASNM, Durban 2014.
  1. Ebenhan T, Schoeman I, Zeevaart J and Sathekge M. Synthesis of 68Ga-NOTA-RGD PET/CT for lung cancer. WMIC, 18 March 2014. Seoul, South Korea
  1. Ebenhan T, Govender T, Kruger G, Pulker T, Zeevaart J and Sathekge M. FDG and  68Ga-NOTA-UBI30-41 PET/CT imaging of infection. WMIC, 18 March 2014. Seoul, South Korea.
  1. Ebenhan T, Govender T, Kruger G, Pulker T, Zeevaart J and Sathekge M. Synthesis of 68Ga-NOTA-UBI30-41 PET/CT imaging of infection. WMIC, 18 March 2014. Seoul, South Korea
  1. Vorster M, Sathekge M. Evaluating the role of 68Ga citrate-PET/CT in TB lung. UP Academic Day 2014.
  1. M M Sathekge. Guest Speaker. Imaging of Drug Resistant TB Decoded. IRCT 2013, WARMTH, 21 November 2013. Manila, Philippines.
  1. Sathekge M M. PET in O&G. Guest Speaker. UP,5 June 2014. Vienna, Austria
  1. Sathekge M M. FDG PET in TB & HIV. Faculty-Invited Speaker. ISORBE,28 April 2014. Helsinki, Finland
  1. Sathekge M M. Tuberculosis. Faculty-Invited Speaker. SNMMI, St Louis, USA,7 June 2014. St Louis, USA
  1. M M Sathekge. New Gallium labeled radiopharmaceuticals in infection, IRIST, Cancun, Mexico. 26 August 2014 Faculty-Invited
  1. M M Sathekge. New developments in PRRT, WARMTH, Cancun, Mexico. 27 August 2014 Faculty-Invited
  1. M M Sathekge. PRRT Panel of Experts, WARMTH, Cancun, Mexico. 27 August 2014 Faculty-Invited
  1. M M Sathekge. SPECT and PET in Bone Infection, World Federation of Nuclear Medicine and Biology Congress, Cancun, Mexico. 27-31 August 2014 Faculty-Invited
  1. M M Sathekge. PRRT In South Africa, NTP-ANSTO, World Federation of Nuclear Medicine and Biology Congress, Cancun, Mexico. 27-31 August 2014 Faculty-Invited
  1. Vorster M, Sathekge M. Evaluating the role of 68Ga citrate-PET/CT in TB lung. EANM Congress, Gothenburg, Sweden. 17-22 October 2014
  1. M M Sathekge. Peptides, small molecules and antibiotics for hybrid PET/CT and SPECT/CT imaging of infection, EANM Congress, Gothenburg, Sweden. 17-22 October 2014 Faculty-Invited

 

Media articles/interviews/etc.:

SAJS – PRRT Guidelines in South Africa

Medical Chronicle – PET in SA

SAMA Insider – Supplementary PhD scholarship for SA

Medical Chronicle – PET/CT in Oncology

The First SIRT in South Africa;

  • SABC 1
  • SABC 2
  • SABC 3
  • E-TV News
  • E-TV Life
  • E-TV Morning Edition
  • Pretoria News
  • The Star
  • Die Beeld
  • Citizen
  • Sowetan

                                                          

Other:

Awards/distinctions of the past 5 years:

  1. The first winner of the late Ralph Kirsch Golden Pen Award for the most cited article, published in the  SAMJ, _ Prof MM Sathekge
  1. 1st prize IRIST Oral Presentation: Vorster M, Sathekge M. New Gallium Labelled radiopharmaceuticals in inflammation/ infection. Word Federation of Nuclear Medicine & Biology Congress, Cancun Mexico 2014.
  1. SAMA Merit Branch Award: Outstanding Leadership: 2014
  1. Best MMed/MDent Publication(Runners-up): Hatutale, A Vorster M, Ankrah AO, Rheeder P, Sathekge MM -  Association of hemodynamic response during dipyridamole stress testing with 99mTc-MIBI SPET myocardial   perfusion image findings in Hellenic Journal of  Nuclear Medicine
  1. SARA- Outstanding teaching, excellence in research supervision and support of student systems 2014
  1. Honored to present the Highlights Lecture. Word Federation of Nuclear Medicine & Biology Congress, Cancun   Mexico 2014.
  1. Best Publication on Best Team Effort: Sathekge M, Wagener J, Smith SV, Soni N, Marjanovic-Painter B, Zinn C, Van de  Wiele C, D'Asseler Y, Perkins G, Zeevaart JR - Biodistribution and dosimetry of 195mPt-cisplatin in  normal volunteers. Imaging agent for single photon emission computed tomography in Nuklearmedizin
  1. Winner of the 2014 top National SAMA-Bonitas Award: Fellowship in Art & Science of Medicine Award – Prof MM Sathekge
  1. 1st   prize for the best oral presentation: IO Lawal, T Boshomane, M Vorster, M Sathekge. Diagnostic value of 68Ga-DOTATATE PET/CT in neuroendocrine tumours. Faculty Day, UP. 18 August 2015.
  1. Poster presentation: K Ololade, N Mokgoro, M Sathekge. IPET, IAEA, Vienna. 9 October 2015.
  1. Best MMed/MDent Publication (Runners-up):– University of Pretoria. Zinn C, Vorster M, Sathekge MM. Spinal Tuberculosis Evaluated by Means of 18F-FDG PET/CT: Pilot Study.TONMED 2014. 6-11
  1. Guest Editor for Semin Nucl Med (Position paper journal for Nuclear Medicine) For Ga68 PET/CT
  1. Best Overall Pre-Clinical Publication – University of Pretoria. Ebenhan T, Zeevaart JR, Venter JD, Govender T, Kruger GH, Jarvis NV, Sathekge  MM. Preclinical evaluation of 68Ga-labeled1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014 Feb;55(2):308-14
  1. Special lecture and Mahathma Gandhi Award from Nuclear Cardiology Society of India, 2nd October 2015.
  1. Best Poster_SASNM 2016 – University of Pretoria. Ebenhan T, Zeevaart JR, Venter JD, Govender T, Kruger GH, Jarvis NV, Sathekge  MM. Preclinical evaluation of 68Ga-labeled1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.

 

 

updated 22/05/2019

Copyright © University of Pretoria 2024. All rights reserved.

COVID-19 Corona Virus South African Resource Portal

To contact the University during the COVID-19 lockdown, please send an email to [email protected]

FAQ's Email Us Virtual Campus Share Cookie Preferences